Old Web
English
Sign In
Acemap
>
Paper
>
Biosimilar Cost Savings in the United States
Biosimilar Cost Savings in the United States
2017
Andrew W. Mulcahy
Jakub P. Hlavka
Spencer R. Case
Keywords:
Health economics
Biosimilar
Health policy
Actuarial science
Economic growth
Business
Prescription costs
cost savings
Public economics
health insurance
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI
[]